The University of Siena PhD Course in
Genetics, Oncology and Clinical Medicine


PhD Graduate

Mario MANCINO

PhD Program years: 2005 - 2009







PUBLICATIONS DURING THE PHD PROGRAM
  1. The ErbB receptors and their ligands in cancer: an overview.
    Normanno N, Bianco C, Strizzi L, Mancino M, Maiello MR, De Luca A, Caponigro F, Salomon DS.
    Curr Drug Targets. 2005 May;6(3):243-57. Review.

  2. Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis.
    Normanno N, De Luca A, Aldinucci D, Maiello MR, Mancino M, D'Antonio A, De Filippi R, Pinto A.
    Endocr Relat Cancer. 2005 Jun;12(2):471-82.

  3. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in breast cancer: current status and future development.
    Normanno N, De Luca A, Maiello MR, Mancino M, D'Antonio A, Macaluso M, Caponigro F, Giordano A.
    Front Biosci. 2005 Sep 1;10:2611-7.

  4. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.
    Gene. 2006 Jan 17;366(1):2-16. Epub 2005 Dec 27. Review.

  5. The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
    Normanno N, De Luca A, Maiello MR, Campiglio M, Napolitano M, Mancino M, Carotenuto A, Viglietto G, Menard S.
    J Cell Physiol. 2006 May;207(2):420-7.

  6. Identification of cripto-1 as a novel serologic marker for breast and colon cancer.
    Bianco C, Strizzi L, Mancino M, Rehman A, Hamada S, Watanabe K, De Luca A, Jones B, Balogh G, Russo J, Mailo D, Palaia R, D'Aiuto G, Botti G, Perrone F, Salomon DS, Normanno N.
    Clin Cancer Res. 2006 Sep 1;12(17):5158-64.

  7. Development of leiomyosarcoma of the uterus in MMTV-CR-1 transgenic mice.
    Strizzi L, Bianco C, Hirota M, Watanabe K, Mancino M, Hamada S, Raafat A, Lawson S, Ebert AD, D'Antonio A, Losito S, Normanno N, Salomon DS.
    J Pathol. 2007 Jan;211(1):36-44.

  8. Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells.
    Mancino M, Strizzi L, Wechselberger C, Watanabe K, Gonzales M, Hamada S, Normanno N, Salomon DS, Bianco C.
    J Cell Physiol. 2008 Apr;215(1):192-203.

  9. Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling.
    Normanno N, Campiglio M, Maiello MR, De Luca A, Mancino M, Gallo M, D'Alessio A, Menard S.
    Breast Cancer Res Treat. 2008 Nov;112(1):25-33. Epub 2007 Nov 30.

  10. Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.
    Bianco C, Strizzi L, Mancino M, Watanabe K, Gonzales M, Hamada S, Raafat A, Sahlah L, Chang C, Sotgia F, Normanno N, Lisanti M, Salomon DS.
    Am J Pathol. 2008 Feb;172(2):345-57. Epub 2008 Jan 17.

  11. Neuronal guidance protein Netrin-1 induces differentiation in human embryonal carcinoma cells.
    Mancino M, Esposito C, Watanabe K, Nagaoka T, Gonzales M, Bianco C, Normanno N, Salomon DS, Strizzi L.
    Cancer Res. 2009 Mar 1;69(5):1717-21. Epub 2009 Feb 17.

ABSTRACTS OF CONFERENCE DURING THE PHD PROGRAM
  1. Conference abstract title
    Conference title, Date
    Location

ACTIVITY DURING THE PHD PROGRAM

TRAINING PERIOD ABROAD
  • National Institute of Health-National Cancer Institute in Bethesda, USA
  • 2008: twelve months
  • Gerry Melino Lab, Toxicology Unit, Medical Research Council Leicester, UK
  • 2009: three months